Alzheimer Disease and Associated Disorders

Journal

Publication Venue For

  • Both financial and cognitive decline predict clinical progression in MCI.  30:27-34. 2016
  • Geographic distribution of dementia mortality: Elevated mortality rates for black and white Americans by place of birth.  25:196-202. 2011
  • Financial capacity of older African Americans with amnestic mild cognitive impairment.  24:365-371. 2010
  • Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.  22:269-277. 2008
  • Brain N-acetylaspartate is reduced in Parkinson disease with dementia.  22:54-60. 2008
  • Do work-related stress and reactivity to stress predict dementia more than 30 years later?.  21:205-209. 2007
  • The severe mini-mental state examination: A new neuropsychologic instrument for the bedside assessment of severely impaired patients with Alzheimer disease.  14:168-175. 2000
  • Densitometric analysis of G(αo) protein subunit levels from postmortem Alzheimer disease hippocampal and prefrontal cortical membranes.  14:53-57. 2000
  • Methanesulfonyl fluoride (MSF): A double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type.  13:20-25. 1999
  • Activities of daily living as an outcome measure in clinical trials of dementia drugs: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.  11:6-7. 1997
  • Objective psychometric tests in clinical trials of dementia drugs: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.  11:34-38. 1997
  • Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's disease assessment scale that broaden its scope.  11. 1997
  • Attentional problems and older drivers.  11:42-47. 1997
  • Clinical and research issues on older drivers: Future directions.  11:3-7. 1997
  • Dementia and driving: An attempt at consensus.  11:28-37. 1997
  • Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study..  11 Suppl 2:S13-S21. 1997
  • Ethical issues in dementia drug development: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.  11:26-28. 1997
  • Knowledge about Alzheimer disease among primary care physicians, psychologists, nurses, and social workers.  11:99-106. 1997
  • The role of selective attention in driving and dementia of the Alzheimer type.  11:48-56. 1997
  • Relationship between level of insight and severity of dementia in Alzheimer disease.  9:101-104. 1995
  • Determining the competency of Alzheimer patients to consent to treatment and research.  8:5-18. 1994
  • Autopsy in dementing illness: Who participates?.  7:80-87. 1993

    • International Standard Serial Number (issn)

  • 0893-0341